The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Utz, U.
Right arrow Articles by Biddison, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Utz, U.
Right arrow Articles by Biddison, W. E.

The Journal of Immunology, Vol 149, Issue 1 214-221, Copyright © 1992 by American Association of Immunologists

ARTICLES

Presentation of three different viral peptides, HTLV-1 Tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule

U Utz, S Koenig, JE Coligan and WE Biddison
Molecular Immunology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH), Bethesda, MD 20892.

To determine whether similar or dissimilar molecular features of class I molecules are involved in the presentation of structurally distinct peptides, we have investigated the influence of different pockets of the HLA-A2.1 molecule on the presentation of three different viral peptides. HTLV-I Tax peptide 12-19, HCMV gB 619-628, and influenza M1 58-66 are minimal peptides that induce HLA-A2.1-restricted noncross- reactive CTL. A detailed analysis of the structural features of HLA- A2.1 that are involved in peptide presentation was undertaken using a panel of 11 HLA-A2 mutants with single amino acid substitutions within pockets present in the peptide binding site. Nine of the 11 mutants affected presentation of each of the three peptides, whereas the other two mutants had negative effects on presentation of only two of these viral peptides. These results indicate that common structural features in HLA-A2 determine the binding of different peptides, and help to provide a plausible explanation for how structurally diverse peptides bind to HLA-A2.


This article has been cited by other articles:


Home page
 J. Virol.Home page
D. J. C. Miles, M. van der Sande, D. Jeffries, S. Kaye, J. Ismaili, O. Ojuola, M. Sanneh, E. S. Touray, P. Waight, S. Rowland-Jones, et al.
Cytomegalovirus Infection in Gambian Infants Leads to Profound CD8 T-Cell Differentiation
J. Virol., June 1, 2007; 81(11): 5766 - 5776.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Kubota, K. Hanada, Y. Furukawa, K. Arimura, M. Osame, T. Gojobori, and S. Izumo
Genetic Stability of Human T Lymphotropic Virus Type I despite Antiviral Pressures by CTLs
J. Immunol., May 1, 2007; 178(9): 5966 - 5972.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
E. Elkord, P. E. Williams, H. Kynaston, and A. W. Rowbottom
Differential CTLs specific for prostate-specific antigen in healthy donors and patients with prostate cancer
Int. Immunol., October 1, 2005; 17(10): 1315 - 1325.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
N. Harashima, R. Tanosaki, Y. Shimizu, K. Kurihara, T. Masuda, J. Okamura, and M. Kannagi
Identification of Two New HLA-A*1101-Restricted Tax Epitopes Recognized by Cytotoxic T Lymphocytes in an Adult T-Cell Leukemia Patient after Hematopoietic Stem Cell Transplantation
J. Virol., August 1, 2005; 79(15): 10088 - 10092.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Wooldridge, H. A. van den Berg, M. Glick, E. Gostick, B. Laugel, S. L. Hutchinson, A. Milicic, J. M. Brenchley, D. C. Douek, D. A. Price, et al.
Interaction between the CD8 Coreceptor and Major Histocompatibility Complex Class I Stabilizes T Cell Receptor-Antigen Complexes at the Cell Surface
J. Biol. Chem., July 29, 2005; 280(30): 27491 - 27501.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Laugel, J. M. Boulter, N. Lissin, A. Vuidepot, Y. Li, E. Gostick, L. E. Crotty, D. C. Douek, J. Hemelaar, D. A. Price, et al.
Design of Soluble Recombinant T Cell Receptors for Antigen Targeting and T Cell Inhibition
J. Biol. Chem., January 21, 2005; 280(3): 1882 - 1892.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. K. Baxter, S. J. Gagnon, R. L. Davis-Harrison, J. C. Beck, A.-K. Binz, R. V. Turner, W. E. Biddison, and B. M. Baker
Strategic Mutations in the Class I Major Histocompatibility Complex HLA-A2 Independently Affect Both Peptide Binding and T Cell Receptor Recognition
J. Biol. Chem., July 9, 2004; 279(28): 29175 - 29184.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. J. Gagnon, Z. Wang, R. Turner, M. Damirjian, and W. E. Biddison
MHC Recognition by Hapten-Specific HLA-A2-Restricted CD8+ CTL
J. Immunol., September 1, 2003; 171(5): 2233 - 2241.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Kubota, Y. Furukawa, S. Izumo, K. Usuku, and M. Osame
Degenerate specificity of HTLV-1-specific CD8+ T cells during viral replication in patients with HTLV-1-associated myelopathy (HAM/TSP)
Blood, April 15, 2003; 101(8): 3074 - 3081.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Z. Wang, R. Turner, B. M. Baker, and W. E. Biddison
MHC Allele-Specific Molecular Features Determine Peptide/HLA-A2 Conformations That Are Recognized by HLA-A2-Restricted T Cell Receptors
J. Immunol., September 15, 2002; 169(6): 3146 - 3154.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
S. Hanabuchi, T. Ohashi, Y. Koya, H. Kato, A. Hasegawa, F. Takemura, T. Masuda, and M. Kannagi
Regression of Human T-cell Leukemia Virus Type I (HTLV-I)-Associated Lymphomas in a Rat Model: Peptide-Induced T-Cell Immunity
J Natl Cancer Inst, December 5, 2001; 93(23): 1775 - 1783.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Yague, A. Marina, J. Vazquez, and J. A. Lopez de Castro
Major Histocompatibility Complex Class I Molecules Bind Natural Peptide Ligands Lacking the Amino-terminal Binding Residue in Vivo
J. Biol. Chem., November 16, 2001; 276(47): 43699 - 43707.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
B. M. Baker, R. V. Turner, S. J. Gagnon, D. C. Wiley, and W. E. Biddison
Identification of a Crucial Energetic Footprint on the {alpha}1 Helix of Human Histocompatibility Leukocyte Antigen (Hla)-A2 That Provides Functional Interactions for Recognition by Tax Peptide/Hla-A2-Specific T Cell Receptors
J. Exp. Med., March 5, 2001; 193(5): 551 - 562.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y. Furukawa, R. Kubota, M. Tara, S. Izumo, and M. Osame
Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia
Blood, February 15, 2001; 97(4): 987 - 993.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
R. Holtappels, D. Thomas, and M. J. Reddehase
Identification of a Kd-restricted antigenic peptide encoded by murine cytomegalovirus early gene M84
J. Gen. Virol., December 1, 2000; 81(12): 3037 - 3042.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
A. R. Khan, B. M. Baker, P. Ghosh, W. E. Biddison, and D. C. Wiley
The Structure and Stability of an HLA-A*0201/Octameric Tax Peptide Complex with an Empty Conserved Peptide-N-Terminal Binding Site
J. Immunol., June 15, 2000; 164(12): 6398 - 6405.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Kubota, S. S. Soldan, R. Martin, and S. Jacobson
An Altered Peptide Ligand Antagonizes Antigen-Specific T Cells of Patients with Human T Lymphotropic Virus Type I-Associated Neurological Disease
J. Immunol., May 15, 2000; 164(10): 5192 - 5198.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. A. Lodge, L. A. Jones, R. A. Bader, G. P. Murphy, and M. L. Salgaller
Dendritic Cell-based Immunotherapy of Prostate Cancer: Immune Monitoring of a Phase II Clinical Trial
Cancer Res., February 1, 2000; 60(4): 829 - 833.
[Abstract] [Full Text]

Home page
 Microbiol. Mol. Biol. Rev.Home page
P. Hollsberg
Mechanisms of T-Cell Activation by Human T-Cell Lymphotropic Virus Type I
Microbiol. Mol. Biol. Rev., June 1, 1999; 63(2): 308 - 333.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. P. Bettinotti, C. J. Kim, K.-H. Lee, M. Roden, J. N. Cormier, M. Panelli, K. K. Parker, and F. M. Marincola
Stringent Allele/Epitope Requirements for MART-1/Melan A Immunodominance: Implications for Peptide-Based Immunotherapy
J. Immunol., July 15, 1998; 161(2): 877 - 889.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Kubota, T. Kawanishi, H. Matsubara, A. Manns, and S. Jacobson
Demonstration of Human T Lymphotropic Virus Type I (HTLV-I) Tax-Specific CD8+ Lymphocytes Directly in Peripheral Blood of HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis Patients by Intracellular Cytokine Detection
J. Immunol., July 1, 1998; 161(1): 482 - 488.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. E. Biddison, W. W. Cruikshank, D. M. Center, C. M. Pelfrey, D. D. Taub, and R. V. Turner
CD8+ Myelin Peptide-Specific T Cells Can Chemoattract CD4+ Myelin Peptide-Specific T Cells: Importance of IFN-Inducible Protein 10
J. Immunol., January 1, 1998; 160(1): 444 - 448.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
S. M. O'Herrin, M. S. Lebowitz, J. G. Bieler, B. K. al-Ramadi, U. Utz, A. L.M. Bothwell, and J. P. Schneck
Analysis of the Expression of Peptide-Major Histocompatibility Complexes Using High Affinity Soluble Divalent T Cell Receptors
J. Exp. Med., October 20, 1997; 186(8): 1333 - 1345.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
M Bouvier and D. Wiley
Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules
Science, July 15, 1994; 265(5170): 398 - 402.
[Abstract] [PDF]

Home page
 ScienceHome page
A. Cox, J Skipper, Y Chen, R. Henderson, T. Darrow, J Shabanowitz, V. Engelhard, D. Hunt, and C. Slingluff Jr
Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines
Science, April 29, 1994; 264(5159): 716 - 719.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.